BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9829617)

  • 21. Purinergic signalling: pathophysiology and therapeutic potential.
    Burnstock G
    Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purinergic signaling in healthy and diseased skin.
    Burnstock G; Knight GE; Greig AV
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):526-46. PubMed ID: 22158558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purinergic signalling--an overview.
    Burnstock G
    Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introductory overview of purinergic signalling.
    Burnstock G
    Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advantages of fast-acting ADP receptor blockade in ischemic heart disease.
    Nurden AT; Nurden P
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):158-9. PubMed ID: 12588753
    [No Abstract]   [Full Text] [Related]  

  • 26. Presynaptic adenosine and P2Y receptors.
    Gonçalves J; Queiroz G
    Handb Exp Pharmacol; 2008; (184):339-72. PubMed ID: 18064419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of presynaptic purinoceptors to modulate noradrenaline release from sympathetic nerves in human dental pulp.
    Parker DA; Marino V; Krishna M; Narayanan A; de la Lande IS
    Arch Oral Biol; 2000 Oct; 45(10):827-31. PubMed ID: 10973556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine triphosphate release and purinergic regulation of cholangiocyte transport.
    Feranchak AP; Fitz JG
    Semin Liver Dis; 2002 Aug; 22(3):251-62. PubMed ID: 12360419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purines '96.
    Alexander SP; Ford AP
    Trends Pharmacol Sci; 1996 Nov; 17(11):385-8. PubMed ID: 8990951
    [No Abstract]   [Full Text] [Related]  

  • 30. Purinergic signalling.
    Burnstock G
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S172-81. PubMed ID: 16402102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenine nucleotides as inhibitors of synaptic transmission: role of localised ectonucleotidases.
    Sebastião AM; Cunha RA; Cascalheira JF; Ribeiro JA
    Prog Brain Res; 1999; 120():183-92. PubMed ID: 10550997
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel insights into how purines regulate pituitary cell function.
    Rees DA; Scanlon MF; Ham J
    Clin Sci (Lond); 2003 May; 104(5):467-81. PubMed ID: 12578557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine and P2 receptors in PC12 cells. Genotypic, phenotypic and individual differences.
    Arslan G; Fredholm BB
    Prog Brain Res; 1999; 120():301-10. PubMed ID: 10551006
    [No Abstract]   [Full Text] [Related]  

  • 34. Current status of P2X receptors: distribution and pathophysiological roles.
    Burnstock G
    Proc West Pharmacol Soc; 1999; 42():119-21. PubMed ID: 10697712
    [No Abstract]   [Full Text] [Related]  

  • 35. Regional vascular responses to ATP and ATP analogues in the rabbit kidney in vivo: roles for adenosine receptors and prostanoids.
    Eppel GA; Ventura S; Evans RG
    Br J Pharmacol; 2006 Nov; 149(5):523-31. PubMed ID: 16981003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposal of a guanine-based purinergic system in the mammalian central nervous system.
    Schmidt AP; Lara DR; Souza DO
    Pharmacol Ther; 2007 Dec; 116(3):401-16. PubMed ID: 17884172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurogenic secretion mediated by the purinergic P2Y1 receptor in guinea-pig small intestine.
    Fang X; Hu HZ; Gao N; Liu S; Wang GD; Wang XY; Xia Y; Wood JD
    Eur J Pharmacol; 2006 Apr; 536(1-2):113-22. PubMed ID: 16566916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developments in P2 receptor targeted therapeutics.
    Williams M
    Prog Brain Res; 1999; 120():93-106. PubMed ID: 10550990
    [No Abstract]   [Full Text] [Related]  

  • 40. Adenosine monophosphate as a mediator of ATP effects at P1 purinoceptors.
    Ross FM; Brodie MJ; Stone TW
    Br J Pharmacol; 1998 Jun; 124(4):818-24. PubMed ID: 9690876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.